IBRX - ImmunityBio, Inc.
3
0.010 0.333%
Share volume: 4,124,543
Last Updated: 03-07-2025
Research and Development in Biotechnology (except Nanobiotechnology):
-0.45%
PREVIOUS CLOSE
CHG
CHG%
$2.99
0.01
0.00%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 08-08-2023 | 11-09-2023 | 03-19-2024 | 05-09-2024 | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-03-2025 | |
| Total revenue | 41.000 K | 82.000 K | 139.000 K | 40.000 K | 40.000 K | 1.047 M | 6.106 M | 7.552 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 41.000 K | 82.000 K | 139.000 K | 40.000 K | 40.000 K | 1.047 M | 6.106 M | 7.552 M | |
| 100.00% | 69.51% | -71.22% | 0.00% | 2,517.50% | 483.19% | 23.68% | |||
| Operating expenses | 85.186 M | 80.218 M | 84.642 M | 95.236 M | 95.236 M | 100.380 M | 86.359 M | 76.952 M | |
| Selling general and admin | 32.018 M | 31.816 M | 33.110 M | 41.885 M | 41.885 M | 49.251 M | 35.916 M | 41.731 M | |
| Research and development | 53.168 M | 48.402 M | 51.532 M | 53.351 M | 53.351 M | 51.129 M | 50.443 M | 35.221 M | |
| Total expenses | 89.143 M | 81.473 M | 84.642 M | 95.236 M | 95.236 M | 100.380 M | 86.359 M | 76.952 M | |
| -8.60% | 3.89% | 12.52% | 0.00% | 5.40% | -13.97% | -10.89% | |||
| Operating income | -89.102 M | -81.391 M | -84.503 M | -95.196 M | -95.196 M | -99.333 M | -80.253 M | -69.400 M | |
| Ebit | -89.102 M | -81.391 M | -84.503 M | -99.742 M | -95.196 M | -97.456 M | -47.303 M | -22.792 M | |
| Pretax income | -138.213 M | -95.642 M | -233.454 M | -134.130 M | -134.130 M | -134.584 M | -85.752 M | -59.179 M | |
| -30.80% | 144.09% | -42.55% | 0.00% | 0.34% | -36.28% | -30.99% | |||
| Income tax | 0.000 | 0.000 | -40.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -137.879 M | -95.582 M | -233.392 M | 0.000 | -134.109 M | 0.000 | 0.000 | 0.000 | |
| 30.68% | -144.18% | 100.00% | 100.00% | ||||||
| Net income | -137.879 M | -95.582 M | -233.392 M | -134.130 M | -134.109 M | -134.584 M | -85.752 M | -59.179 M | |
| 30.68% | -144.18% | 42.53% | 0.02% | -0.35% | 36.28% | 30.99% |